Amneal Pharmaceuticals, Inc. splits its revenue into 3 lines in its filings. The largest line in Q2 of fiscal 2026, the quarter ended Jun 30, 2026 was Affordable Medicines at $489.9 million, 62% of the total.
USD in millions. The percent under a figure is the change from the same quarter a year earlier.
| Line |
TTM
Jun 30, 2026
|
Q2 FY2026
Jun 30, 2026
|
Q1 FY2026
Mar 31, 2026
|
Q4 FY2025
Dec 31, 2025
|
Q3 FY2025
Sep 30, 2025
|
Q2 FY2025
Jun 30, 2025
|
Q1 FY2025
Mar 31, 2025
|
Q4 FY2024
Dec 31, 2024
|
Q3 FY2024
Sep 30, 2024
|
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
3,118
|
796
|
723
|
814
|
785
|
725
|
695
|
731
|
702
|
| Affordable Medicines |
—
|
490
+13.0%
share 61.5%
|
423
+2.1%
share 58.6%
|
—
|
—
|
433
share 59.8%
|
415
share 59.6%
|
—
|
—
|
| Av KARE |
—
|
157
-3.7%
share 19.7%
|
166
-3.7%
share 23.0%
|
211
+23.7%
share 25.9%
|
199
+24.5%
share 25.3%
|
163
share 22.5%
|
172
share 24.8%
|
170
share 23.3%
|
159
share 22.7%
|
| Specialty |
—
|
149
+16.6%
share 18.8%
|
—
|
167
+38.1%
share 20.5%
|
125
+8.3%
share 16.0%
|
128
share 17.7%
|
—
|
121
share 16.5%
|
116
share 16.5%
|
How these figures are calculated
Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- AMRX (Nasdaq)
- Fiscal year ends
- December 31
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1723128
- Former names
- Atlas Holdings, Inc. (until Apr 13, 2018)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.